About Us

THE COMPANY

Swecure is a Swedish biotechnology company developing bacterial therapeutics for immunoregulatory disorders linked to the microbiome.

 

Swecure was founded 2012 and based on decades of research on the infant gut microbiota and its relation to chronic diseases such as allergy and IBD. Through extensive cohort studies where children were followed from infancy to adolescence researchers at the Sahlgrenska Academy at Göteborg University obtained unique knowledge about the correlations between certain bacteria in the microbiome and disease development later in life.

 

Currently the company is focusing on developing a range of bacterial compositions with lead products aimed at IBD and allergy.

 

The company is based in Stockholm and the Research and development department is based in Gothenburg.

VISION

To be able to treat and prevent some of the most common chronic diseases seen today

MISSION

To produce a range of bacterial therapeutics aimed at diseases with a clear link to dysbiosis of the microbiome

Headquarters
Stureplan 15, SE-11145 Stockholm, Sweden
+46 70 791 34 64, info@swecure.com
www.swecure.com

Copyright ©, 2016 Swecure
Research and Development
AstraZeneca Bio Venture Hub, SE-431 83 Mölndal, Sweden


All rights reserved
Menu
Close